• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

蛋白酶体激活剂REGalpha(PA28alpha)的结构。

Structure of the proteasome activator REGalpha (PA28alpha).

作者信息

Knowlton J R, Johnston S C, Whitby F G, Realini C, Zhang Z, Rechsteiner M, Hill C P

机构信息

Department of Biochemistry, University of Utah, Salt Lake City 84132, USA.

出版信息

Nature. 1997 Dec 11;390(6660):639-43. doi: 10.1038/37670.

DOI:10.1038/37670
PMID:9403698
Abstract

The specificity of the 20S proteasome, which degrades many intracellular proteins, is regulated by protein complexes that bind to one or both ends of the cylindrical proteasome structure. One of these regulatory complexes, the 11S regulator (known as REG or PA28), stimulates proteasome peptidase activity and enhances the production of antigenic peptides for presentation by class I molecules of the major histocompatibility complex (MHC). The three REG subunits that have been identified, REGalpha, REGbeta and REGgamma (also known as the Ki antigen), share extensive sequence similarity, apart from a highly variable internal segment of 17-34 residues which may confer subunit-specific properties. REGalpha and REGbeta preferentially form a heteromeric complex, although purified REGalpha forms a heptamer in solution and has biochemical properties similar to the heteromeric REGalpha/REGbeta complex. We have now determined the crystal structure of human recombinant REGalpha at 2.8 A resolution. The heptameric barrel-shaped assembly contains a central channel that has an opening of 20 A diameter at one end and another of 30 A diameter at the presumed proteasome-binding surface. The binding of REG probably causes conformational changes that open a pore in the proteasome alpha-subunits through which substrates and products can pass.

摘要

20S蛋白酶体可降解多种细胞内蛋白质,其特异性受与圆柱形蛋白酶体结构一端或两端结合的蛋白质复合物调控。其中一种调控复合物,即11S调节因子(称为REG或PA28),可刺激蛋白酶体肽酶活性,并增强主要组织相容性复合体(MHC)I类分子呈递的抗原肽的产生。已鉴定出的三个REG亚基,REGα、REGβ和REGγ(也称为Ki抗原),除了一段17 - 34个残基的高度可变内部片段可能赋予亚基特异性特性外,它们具有广泛的序列相似性。REGα和REGβ优先形成异源复合物,尽管纯化的REGα在溶液中形成七聚体,且具有与异源REGα/REGβ复合物相似的生化特性。我们现已确定了人重组REGα在2.8埃分辨率下的晶体结构。七聚体桶状组装体包含一个中央通道,该通道一端的开口直径为20埃,在假定的蛋白酶体结合表面的另一端开口直径为30埃。REG的结合可能会引起构象变化,从而在蛋白酶体α亚基中打开一个孔,底物和产物可通过该孔。

相似文献

1
Structure of the proteasome activator REGalpha (PA28alpha).蛋白酶体激活剂REGalpha(PA28alpha)的结构。
Nature. 1997 Dec 11;390(6660):639-43. doi: 10.1038/37670.
2
The proteasome activator 11 S REG (PA28) and class I antigen presentation.蛋白酶体激活剂11S REG(PA28)与I类抗原呈递。
Biochem J. 2000 Jan 1;345 Pt 1(Pt 1):1-15.
3
The proteasome activator 11 S REG or PA28: chimeras implicate carboxyl-terminal sequences in oligomerization and proteasome binding but not in the activation of specific proteasome catalytic subunits.蛋白酶体激活剂11S REG或PA28:嵌合体表明羧基末端序列参与寡聚化和蛋白酶体结合,但不参与特定蛋白酶体催化亚基的激活。
J Mol Biol. 2000 Jun 9;299(3):641-54. doi: 10.1006/jmbi.2000.3800.
4
Structural basis for the activation of 20S proteasomes by 11S regulators.11S调节因子激活20S蛋白酶体的结构基础。
Nature. 2000 Nov 2;408(6808):115-20. doi: 10.1038/35040607.
5
Characterization of recombinant REGalpha, REGbeta, and REGgamma proteasome activators.重组REGα、REGβ和REGγ蛋白酶体激活剂的特性分析。
J Biol Chem. 1997 Oct 10;272(41):25483-92. doi: 10.1074/jbc.272.41.25483.
6
The RTP site shared by the HIV-1 Tat protein and the 11S regulator subunit alpha is crucial for their effects on proteasome function including antigen processing.HIV-1反式激活蛋白(Tat蛋白)与11S调节亚基α所共有的RTP位点,对于它们影响包括抗原加工在内的蛋白酶体功能至关重要。
J Mol Biol. 2002 Nov 1;323(4):771-82. doi: 10.1016/s0022-2836(02)00998-1.
7
Identification of an activation region in the proteasome activator REGalpha.蛋白酶体激活剂REGalpha中一个激活区域的鉴定
Proc Natl Acad Sci U S A. 1998 Mar 17;95(6):2807-11. doi: 10.1073/pnas.95.6.2807.
8
The proteasome activator 11 S regulator or PA28. Contribution By both alpha and beta subunits to proteasome activation.蛋白酶体激活剂11S调节因子或PA28。α亚基和β亚基对蛋白酶体激活的作用。
J Biol Chem. 1998 Nov 13;273(46):30660-8. doi: 10.1074/jbc.273.46.30660.
9
Proteasome activation by REG molecules lacking homolog-specific inserts.缺乏同源特异性插入片段的REG分子对蛋白酶体的激活作用。
J Biol Chem. 1998 Apr 17;273(16):9501-9. doi: 10.1074/jbc.273.16.9501.
10
Properties of the nuclear proteasome activator PA28gamma (REGgamma).核蛋白酶体激活剂PA28γ(REGγ)的特性
Arch Biochem Biophys. 2000 Nov 15;383(2):265-71. doi: 10.1006/abbi.2000.2086.

引用本文的文献

1
Current landscape of the immunoproteasome: implications for disease and therapy.免疫蛋白酶体的当前态势:对疾病与治疗的影响
Cell Death Discov. 2025 Aug 25;11(1):406. doi: 10.1038/s41420-025-02698-0.
2
Not Just PA28γ: What We Know About the Role of PA28αβ in Carcinogenesis.不仅仅是PA28γ:我们对PA28αβ在致癌作用中的作用的了解。
Biomolecules. 2025 Jun 16;15(6):880. doi: 10.3390/biom15060880.
3
Mechanisms of ubiquitin-independent proteasomal degradation and their roles in age-related neurodegenerative disease.不依赖泛素的蛋白酶体降解机制及其在年龄相关性神经退行性疾病中的作用。
Front Cell Dev Biol. 2025 Feb 7;12:1531797. doi: 10.3389/fcell.2024.1531797. eCollection 2024.
4
Genetic insights into the effect of trace elements on cardiovascular diseases: multi-omics Mendelian randomization combined with linkage disequilibrium score regression analysis.微量元素对心血管疾病影响的遗传学见解:多组学孟德尔随机化结合连锁不平衡评分回归分析
Front Immunol. 2024 Dec 3;15:1459465. doi: 10.3389/fimmu.2024.1459465. eCollection 2024.
5
A lesson in symmetry.一堂关于对称的课。
Nat Struct Mol Biol. 2024 Dec;31(12):1813. doi: 10.1038/s41594-024-01437-w.
6
Visualizing chaperone-mediated multistep assembly of the human 20S proteasome.可视化伴侣介导的人 20S 蛋白酶体多步骤组装。
Nat Struct Mol Biol. 2024 Aug;31(8):1176-1188. doi: 10.1038/s41594-024-01268-9. Epub 2024 Apr 10.
7
Structural Outlier Detection and Zernike-Canterakis Moments for Molecular Surface Meshes-Fast Implementation in Python.用于分子表面网格的结构异常检测和泽尼克-坎特拉基斯矩——Python 中的快速实现
Molecules. 2023 Dec 21;29(1):52. doi: 10.3390/molecules29010052.
8
The YΦ motif defines the structure-activity relationships of human 20S proteasome activators.YΦ 基序定义了人源 20S 蛋白酶体激活剂的结构-活性关系。
Nat Commun. 2022 Mar 9;13(1):1226. doi: 10.1038/s41467-022-28864-x.
9
Functional Differences between Proteasome Subtypes.蛋白酶体亚型的功能差异。
Cells. 2022 Jan 26;11(3):421. doi: 10.3390/cells11030421.
10
PA28γ: New Insights on an Ancient Proteasome Activator.PA28γ:古老蛋白酶体激活剂的新见解。
Biomolecules. 2021 Feb 5;11(2):228. doi: 10.3390/biom11020228.